Products

BIOPLEX 2200 ANA SCREEN WITH MEDICAL DECISION SUPPORT SOFTWARE FOR USE WITH BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM
BIO-RAD LABORATORIES
Clinical Decision Support & Reference
The BioPlex 2200 ANA Screen with Medical Decision Support Software is an FDA-cleared, fully automated multiplex immunoassay system by Bio-Rad Laboratories, designed for the simultaneous detection of autoantibodies and other analytes to aid in the diagnosis of systemic autoimmune and infectious diseases, utilizing an interpretive software algorithm for result association.

See all 1 product →

About BIO-RAD LABORATORIES

Bio-Rad Laboratories is a prominent global developer and manufacturer of specialized technological products catering to both the life science research and clinical diagnostics markets. For over seven decades, the company has been instrumental in providing innovative tools and services that accelerate scientific discovery and enhance healthcare outcomes. Their extensive portfolio for life science research encompasses instruments, software, consumables, reagents, and educational content, crucial for advancements in areas such as cell biology, gene expression, protein purification, protein quantitation, and drug discovery and manufacturing.

In the realm of clinical diagnostics, Bio-Rad’s sophisticated products and systems deliver high-value clinical information across critical areas including blood transfusion, diabetes monitoring, autoimmune disease testing, and infectious disease testing. These diagnostic tools are essential for supporting the accurate diagnosis, effective monitoring, and appropriate treatment of a wide array of diseases and medical conditions. Furthermore, Bio-Rad is a recognized leader in clinical quality control products and information systems, playing a vital role in ensuring the accuracy and reliability of clinical test results globally. The company is also actively exploring and integrating artificial intelligence to transform workflows, accelerate insights, and support precision diagnostics from early drug discovery to manufacturing scale-up, including AI-powered tools for experimental design and high-throughput screening.

What Physicians Need to Know

AI-Powered Diagnostics & Research
Bio-Rad leverages AI and machine learning across the entire discovery-to-diagnosis pipeline. This includes accelerating experimental design, high-throughput discovery (e.g., image-based assays, omics integration, digital PCR data modeling), and AI-assisted biomarker discovery. Their 'A.I.den' antibody search engine uses ML to provide highly relevant results for researchers.
Specialized Clinical Diagnostics
The company specializes in a broad range of clinical diagnostics, including autoimmune testing (e.g., BioPlexu00ae 2200 System Interpretive Software for Antinuclear Antibodies), blood transfusion, diabetes monitoring, infectious disease testing, and genetic disorders screening. They are a leading supplier in many of these areas.
Advanced Quality Control (QC) Solutions
Bio-Rad offers comprehensive QC data management through Unity Software Solutions (Unity Real Time, UnityWeb, Unity Next Peer QC). These platforms provide peer comparison, daily QC, advanced charts, and audit trails, backed by access to the industry's largest peer groups to ensure reliable patient results.
Cloud-Based Data Management & Connectivity
Their solutions, such as BR.io and Unity Next Peer QC, utilize cloud platforms (e.g., AWS IoT Greengrass, Amazon SageMaker, Amazon S3) for seamless instrument connectivity, remote experiment design, data management, and analysis. This facilitates efficient storage, processing, and global collaboration.
Proprietary Digital Biology Technologies
Bio-Rad is known for its innovative Droplet Digital PCR (ddPCR) platform, which enables high sensitivity and precision in applications like oncology mutation detection and viral load monitoring.
Physician Tip

For physicians, Bio-Rad Laboratories stands out by offering tools that enhance diagnostic accuracy and streamline clinical workflows. Their FDA-cleared interpretive software for autoimmune testing, for instance, provides reliable, actionable insights, potentially reducing diagnostic time and improving treatment decisions. The cloud-connected diagnostic systems and AI analytics facilitate faster data access and automated analysis, which can lead to more informed clinical decisions and improved patient outcomes. Furthermore, their robust quality control solutions and access to extensive peer group data instill greater confidence in test results, ensuring the reliability essential for patient care. Bio-Rad's commitment to cybersecurity for connected medical devices also helps safeguard sensitive patient data.

Bio-Rad's software solutions, such as IH-Com and IH-Web, are designed to connect their diagnostic systems seamlessly with Laboratory Information Systems (LIS). Their cloud-based platforms, like BR.io and Unity Next Peer QC, offer remote accessibility and data management, promoting integration across different lab environments and supporting global collaboration. They also offer compatibility with various diagnostic analyzers, including Roche systems, through their Unity software solutions.

Products by BIO-RAD LABORATORIES

1 product in the directory

BIOPLEX 2200 ANA SCREEN WITH MEDICAL DECISION SUPPORT SOFTWARE FOR USE WITH BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM
BIO-RAD LABORATORIES
Clinical Decision Support & Reference
The BioPlex 2200 ANA Screen with Medical Decision Support Software is an FDA-cleared, fully automated multiplex immunoassay system by Bio-Rad Laboratories, designed for the simultaneous detection of autoantibodies and other analytes to aid in the diagnosis of systemic autoimmune and infectious diseases, utilizing an interpretive software algorithm for result association.

What the Web Says

Bio-Rad Laboratories generally receives mixed reviews. While their products, particularly in the life sciences and clinical diagnostics, are often praised for their quality and reliability, the company culture and employee experience are frequently cited as areas for improvement. Employees often highlight a lack of work-life balance and internal communication issues.

Overall: Mixed

Strengths

  • High-quality and reliable products in life sciences and clinical diagnostics.
  • Strong reputation for scientific innovation and research tools.
  • Opportunities for professional growth in specific technical roles.
  • Competitive compensation for certain positions.
  • Impactful work contributing to scientific and medical advancements.
  • Good benefits package for employees.

Limitations

  • Poor work-life balance and long hours are commonly reported.
  • Internal communication issues and lack of transparency from management.
  • Bureaucratic processes and slow decision-making.
  • High employee turnover in some departments.
  • Limited opportunities for advancement outside of specific technical tracks.
  • Culture can be demanding and stressful.

Based on reviews from: Glassdoor, Reddit, G2, Capterra

Last updated: 2026-07-17

Videos

News, demos, and interviews about BIO-RAD LABORATORIES.

Loading videos...

Videos load interactively. If none appear, search YouTube for BIO-RAD LABORATORIES →

View all on YouTube

Press & Coverage

BioSpace
Bio-Rad Laboratories, Inc. Receives FDA Clearance For Novel Interpretive Software Used For Autoimmune Testing
Bio-Rad Laboratories received FDA marketing clearance for its Medical Decision Support Software (MDSS) used with the BioPlex 2200 ANA Screen and BioPlex 2200 System. This software is the first of its kind to be FDA-cleared for correlating patient antibody results with specific autoimmune diseases.
2005-11
Business Wire
Bio-Rad Reports First-Quarter 2026 Financial Results
Bio-Rad Laboratories announced its first-quarter 2026 financial results, with total net sales increasing by 1.1% year-over-year. The company updated its full-year 2026 financial outlook, expecting non-GAAP, currency-neutral revenue to be in the range of a 3.0% decline to 0.5% growth.
2026-04
StockTitan
Bio-Rad to Participate in Upcoming Investor Conferences
Bio-Rad will participate in two investor conferences in Mayu2013June 2026, with CFO Roop K. Lakkaraju hosting fireside chats and one-on-one investor meetings. These include the RBC Capital Markets Global Healthcare Conference and the Jefferies Global Healthcare Conference.
2026-05
Bio-Rad
Bio-Rad Expands Range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes
Bio-Rad expanded its range of TrailBlazer Kits for antibody conjugation to StarBright Dyes, increasing access to these dyes for flow cytometry and Western blot applications in immunology research.
2026-05
Investing.com
Elliott builds 'sizeable' stake in med tech firm Bio-Rad, WSJ reports
Elliott Investment Management has reportedly built a 'sizeable' stake in Bio-Rad Laboratories, planning to push for operational overhauls and a boost in its share price.
2026-05
Bio-Rad
Bio-Rad Receives MicroVal Validation for EZ-Checku2122 Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits
Bio-Rad announced it received MicroVal Validation for its EZ-Checku2122 Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits, enhancing its food safety product offerings.
2026-05
Simply Wall St
Bio-Rad Laboratories (BIO) Launches New ddPCR Kits Following A Fair Value Debate
Bio-Rad Laboratories introduced its QX700 System-compatible Vericheck ddPCR Kit portfolio, aimed at quality control workflows in advanced cell and gene therapy development and broader biopharma applications.
2026-07
Bio-Rad
Advancing Scientific Discovery: Bio-Rad Tools Featured in Influential Publications
Bio-Rad highlights its instruments in academic and industry publications, showcasing their use in purifying cancer therapeutics, accelerating SARS-CoV-2 diagnostics development, and optimizing spike protein purification for COVID-19 vaccines.
unknown

Frequently Asked Questions

Bio-Rad leverages AI in various healthcare applications, including high-throughput screening, omics integration, and digital PCR data modeling for biomarker discovery and disease signatures. They also apply AI to support robust assay validation, predictive biomarker modeling, and clinical utility assessment, bridging research and regulated diagnostics. Their software solutions, such as Unity Software and BR.io, incorporate data analysis and management for clinical quality control.
Bio-Rad prioritizes compliance and data privacy, with its Unity Next QC management application hosted on AWS, which is certified for HIPAA, SOC, and ISO 27001. Their quality management system is certified to EN ISO 13485:2016 and adheres to IVDR and FDA regulations. Furthermore, their BR.io cloud platform is GDPR compliant and designed not to process identifiable patient data.
Bio-Rad's pricing for healthcare AI products and services is generally solution-specific, varying based on the instrument systems, software, reagents, and support services required for a particular clinical or research application. For detailed pricing information and tailored solutions, healthcare administrators and physicians should contact their local Bio-Rad sales or customer care representatives.
Bio-Rad provides comprehensive technical support and customer care globally, including a team of PhD scientists for technical and application-related questions. They offer remote service and support through BRiCare, which monitors instrument performance, provides application updates, and offers cybersecurity monitoring. Bio-Rad also provides resources for product literature, educational materials, and instrument service programs to ensure optimal system performance and integration.
Yes, Bio-Rad actively pursues strategic partnerships to enhance its healthcare AI and diagnostic offerings. They have collaborated with companies like Oncocyte Corporation for transplant monitoring using their Droplet Digital PCR technology and with Roche for quality control solutions and data management. These collaborations aim to accelerate innovation and provide integrated solutions for clinical and research needs.
Bio-Rad Laboratories, founded in 1952, is a well-established global leader in life science research and clinical diagnostics, demonstrating long-term stability. With annual revenues around $2.6 billion and approximately 7,400-8,000 employees, the company maintains a strong market presence and continues to invest in innovative solutions, including AI, to advance science and improve healthcare outcomes. Their commitment is evident through ongoing product development and strategic collaborations in the diagnostics space.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.